Showing results (551-560 of 588) with videos related to
Sort By:
Pageof 59
Bioorganic & Medicinal Chemistry Letters|January 4, 2011
A potent and selective indole N-type calcium channel (Ca(v)2.2) blocker for the treatment of painSriram Tyagarajan, Prasun K Chakravarty, Min Park, et al.Journal of Medicinal Chemistry|October 27, 2012
Aminopiperidine sulfonamide Cav2.2 channel inhibitors for the treatment of chronic painPengcheng P Shao, Feng Ye, Prasun K Chakravarty, et al.Molecular Neurodegeneration|May 20, 2017
Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc tau and reduction of tauopathy and cerebrospinal fluid tau in rTg4510 miceNicholas B Hastings, Xiaohai Wang, Lixin Song, et al.The Journal of Pharmacology and Experimental Therapeutics|June 5, 2020
MK-8719, a Novel and Selective O-GlcNAcase Inhibitor That Reduces the Formation of Pathological Tau and Ameliorates Neurodegeneration in a Mouse Model of TauopathyXiaohai Wang, Wenping Li, Jacob Marcus, et al.The Journal of Investigative Dermatology|November 23, 2021
Multi-Trait Genetic Analysis Identifies Autoimmune Loci Associated with Cutaneous MelanomaUpekha E Liyanage, Stuart MacGregor, D Timothy Bishop, et al.The British Journal of Dermatology|March 7, 2023
The MC1R r allele does not increase melanoma risk in MITF E318K carriersCourtney K Wallingford, Anastassia Demeshko, Asha Krishnankutty Krishnakripa, et al.Human Genetics|May 13, 2015
Genetics of skin color variation in Europeans: genome-wide association studies with functional follow-upFan Liu, Mijke Visser, David L Duffy, et al.The Journal of Pharmacology and Experimental Therapeutics|May 5, 2010
Analgesic effects of a substituted N-triazole oxindole (TROX-1), a state-dependent, voltage-gated calcium channel 2 blockerCatherine Abbadie, Owen B McManus, Shu-Yu Sun, et al.Journal of Medicinal Chemistry|August 10, 2021
Invention of MK-8262, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor Backup to Anacetrapib with Best-in-Class PropertiesPetr Vachal, Joseph L Duffy, Louis-Charles Campeau, et al.Bioorganic & Medicinal Chemistry Letters|August 3, 2020
Potent, non-covalent reversible BTK inhibitors with 8-amino-imidazo[1,5-a]pyrazine core featuring 3-position bicyclic ring substitutesJian Liu, Deodial Guiadeen, Arto Krikorian, et al.Pageof 59